Weekly Stock Charts

Jonathan Parsons Rank: 42 Followers: 22 Votes: 3 Years Member: 14 Last Update: 27 June 2017, 19:28 Categories: Chart Patterns
Trend Analysis
Volume Analysis

June 24th 10P Update: What a week! Best trade for me was grabbing some 11c VRX calls posted publicly on TWTR (by SwatOptions). [As an aside, there's lots of folks on TWTR who are excellent option traders - much better than me - many share a ton of info for free. I'm trying to soak up their collective knowledge like a sponge). Anyway, I liked the set-up and it was in a hot sector (biotech). Sold half the next morning at 50c, slapped a GTC sell order at $1 and walked away. Boom! Filled at $1. Anytime I can get a near 10-bagger on my runner with near-zero effort and near-zero stress, I'm a happy camper. What else? I'm focusing on options + long-term 401k trades only now - no swing. The SPX and NDX summation index + IT Vol Momentum indexes are all blood red. The NDX rolled first and I expect it will be the 1st to recover, but for now....no swings for me. What else? The $SPX went inside on the week. Trend is up, so I expect we bust up but better to wait + see. We usually don't see 2 inside weeks in a row, so at the very least I would expect more vol - not less. For next week, I'm watching the banks (stress test results + returning $$$ to shareholders?), steel news (232 findings + Trump executive order?), + MU earnings (tons of call flow, also watch WDC for sympathy plays). What else? Most of the action is in health care + tech.....not retail + energy. Stick with what's working until it stops. Good luck out there!

Less

$ **WELCOME** $

$ *HOW I TRADE IN 7 EASY STEPS*

$ Bullish Stock Screen Results

$ SPX1 - Monthly

$ SPX2 - Weekly SPY

$ SPX3 - IT Volume Momentum Oscillator

$ SPX4 - SPX-specific McClellan Summation Index

$ SPX5 - $TICK - 15 min

$ SPX6 - SVXY (relates to $SPX performance)

$ SPX9 - $VXV-$VIX - 30 min Area, 900

This information is presented for education purposes only. StockCharts.com is not responsible for any comments, advice, or annotations presented on this page. Please review our Terms of Use for more details.